CARR EDWARD 内部人交易：近期 SEC Form 4 交易
过去 18 个月，CARR EDWARD（CIK 1273351）在 1 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-09-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 买入 | 20,000 | $357,600 |
| 2026-09-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 7,928 | $796,209 |
| 2026-09-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 6,771 | $686,376 |
| 2026-09-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 3,501 | $358,467 |
| 2026-09-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 1,100 | $113,520 |
| 2026-09-18 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 700 | $73,073 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 买入 | 16,182 | $289,334 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 买入 | 17,500 | $386,225 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 买入 | 10,000 | $217,700 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 15,852 | $1.3M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 23,465 | $1.9M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 3,865 | $319,481 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 200 | $16,676 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CHIEF ACCOUNTING OFFICER | 卖出 | 300 | $25,659 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18